Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness-Reference-Cited by-同舟云学术

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness

Published:2019-08 Issue:8 Volume:10 Page:e00066
ISSN:2155-384X
Container-title:Clinical and Translational Gastroenterology
language:en
Short-container-title:Clinical and Translational Gastroenterology

Author:

Liebig Stephanie,Stoeckmann Neele,Geier Andreas,Rau Monika,Schattenberg Joern M.,Bahr Matthias J.,Manns Michael P.,Jaeckel Elmar,Schulze-Osthoff Klaus,Bantel Heike

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference49 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

3. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease;Ong;J Hepatol,2008

4. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015

5. Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease;Angulo;Gastroenterology,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation, nutrition, and biological aging: The prognostic role of Naples prognostic score in nonalcoholic fatty liver disease outcomes;Diabetes Research and Clinical Practice;2024-07

2. Controlled attenuation parameter (CAP): the clinical value based on MRI-PDFF in children with obesity;Journal of Pediatric Endocrinology and Metabolism;2024-05-10

3. Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease;Protein & Peptide Letters;2024-04

4. SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum;Journal of Gastroenterology;2022-12-05

5. Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025;Zeitschrift für Gastroenterologie;2022-09